Leadership of Rutgers Cancer Institute of New Jersey

Steven K. Libutti, MD, FACS Director, Rutgers Cancer Institute Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences, and Senior Vice President of Oncology Services, RWJBarnabas Health
H. Richard Alexander, Jr., MD, FACS Chief Surgical Officer and Chief, Surgical Oncology, Rutgers Cancer Institute and Regional Director of Surgery for Monmouth Medical Center, an RWJBH Facility	Wadih Arap, MD, PhD Director, Rutgers Cancer Institute of New Jersey at University Hospital
David A. August, MD Associate Director for Faculty Affairs	Rajat Bannerji, MD, PhD Chief, Hematologic Malignancies
Peter Cole, MD Chief, Pediatric Hematology/Oncology	Dennis Cooper, MD Chief, Blood and Marrow Transplantation
Kevin Coyle Chief Financial Officer	Andrew M. Evens, DO, MSc, FACP Associate Director for Clinical Services, Rutgers Cancer Institute and Medical Director, Oncology Service Line, RWJBarnabas Health
David J. Foran, PhD Chief Informatics Officer and Executive Director of Biomedical Informatics	Shridar Ganesan, MD, PhD Chief, Molecular Oncology and Associate Director for Translational Research
Bruce G. Haffty, MD, MS Associate Vice Chancellor for Cancer Programs and Chair, Radiation Oncology	Howard S. Hochster, MD, FACP Associate Director for Clinical Research, Rutgers Cancer Institute and Director, Clinical Oncology Research, RWJBarnabas Health
Yibin Kang, PhD Associate Director for Consortium Research	Isaac Kim, MD, PhD, MBA Chief, Urologic Oncology
Anita Kinney, PhD Associate Director, Cancer Health Equity and Engagement	Edmund C. Lattime, PhD Associate Director for Research and Education Affairs
Sharon Manne, PhD Associate Director for Cancer Prevention, Control and Population Research	Janice Mehnert, MD Regional Phase I Clinical Program Director
Roger Strair, MD, PhD Chief, Blood Disorders	Antoinet te M. Stroup, PhD Director, New Jersey State Cancer Registry
Linda Tanzer Chief Administrative and Operating Officer and Associate Director for Administration and Planning	Debora h L. Toppmeyer, MD Chief Medical Officer and Chief, Medical Oncology
Eileen White, PhD Deputy Director, Chief Scientific Officer, and Associate Director for Basic Research	Steven Zheng, PhD Chief, Cancer Pharmacology